Optical Coherence Tomography Predictive Biomarkers for Visual Outcomes after Macula-Off Rhegmatogenous Retinal Detachment: A Systematic Review and Meta-Analysis.
Carlà et al.
Am J Ophthalmol·Jan 1, 2026
This meta-analysis of 20 studies (1,841 eyes) found that preoperative OCT biomarkers, particularly intact photoreceptor ellipsoid zone and external limiting membrane, significantly predict better visual outcomes after macula-off rhegmatogenous retinal detachment surgery. However, findings should be interpreted cautiously due to low-quality evidence and high study heterogeneity.
International Consensuses and Guidelines on the Etiology, Diagnosis and Management of Intraocular Foreign Bodies (IOFBs) by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-retina Society (APVRS), and the Academia Retina Internationalis (ARI).
Li et al.
Am J Ophthalmol·Jan 1, 2026
International expert consensus from three major ophthalmology organizations established 49 standardized recommendations for intraocular foreign body (IOFB) management using a modified Delphi method. The guidelines provide systematic approaches to diagnosis, characterization, management, and outcomes assessment for IOFB cases.
PARS PLANA VITRECTOMY-SUPRACHOROIDAL VISCOPEXY FOR RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.
Muni et al.
Retina·Jan 1, 2026
Pars plana vitrectomy with suprachoroidal viscopexy (VIT-SCVEXY) demonstrated comparable reattachment rates and visual outcomes to traditional vitrectomy with scleral buckle for rhegmatogenous retinal detachment repair, with a 91.6% success rate at final follow-up.
NATURAL HISTORY OF TRACTIONAL LAMELLAR MACULAR HOLE.
Kim et al.
Retina·Jan 1, 2026
Tractional lamellar macular holes can be managed conservatively, as patients maintained stable visual acuity over a mean 3.7-year follow-up despite anatomical progression of the hole diameter.
SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY IMAGING OF THE OPTIC PIT COMPLEX.
Spaide
Retina·Jan 1, 2026
Swept source OCT reveals that optic disc pit maculopathy involves a complex spectrum of deep optic nerve abnormalities including lamina cribrosa defects, intraneural cavitations, and multiple pathways for fluid entry into the retina.
The Risk of Retinal Detachment Following Boston Keratoprosthesis Type 1 Implantation: Insights From a Retrospective Case Review.
Elsliger et al.
Am J Ophthalmol·Jan 1, 2026
In this retrospective series of 157 eyes with Boston Type 1 keratoprosthesis, 17.2% developed retinal detachment within 8 years, with aniridia being a significant risk factor (OR: 2.79).
Innovative Non-Inverted ILM Free Flap Covering Technique for Unclosed Macular Hole Repair.
Zhang et al.
Am J Ophthalmol·Jan 1, 2026
A novel non-inverted ILM free flap technique combined with SPOT (sub-PFCL injection of OVD) achieved 100% anatomical closure in 8 persistent unclosed macular holes within one month, with visual acuity improvement in all cases.
SOCIODEMOGRAPHIC FACTORS AFFECTING PRESENTATION IN PEDIATRIC RHEGMATOGENOUS RETINAL DETACHMENT.
Zafar et al.
Retina·Jan 1, 2026
In pediatric rhegmatogenous retinal detachment, older age and female gender were associated with more favorable presentation characteristics, while insurance status significantly influenced follow-up compliance but socioeconomic factors did not impact surgical outcomes.
RATE AND SEVERITY OF EPIRETINAL MEMBRANE FORMATION AFTER SCLERAL BUCKLING SURGERY.
Wang et al.
Retina·Jan 1, 2026
Epiretinal membrane develops in 13.4% of eyes following scleral buckling for rhegmatogenous retinal detachment, with most cases managed conservatively and showing visual improvement over time.
ANGULAR SIGN OF HENLE FIBER LAYER HYPERREFLECTIVITY IN CONTUSION MACULOPATHY: A Multimodal Imaging Analysis.
Gundlach et al.
Retina·Jan 1, 2026
This multimodal imaging study identifies angular sign of Henle fiber layer hyperreflectivity as a distinctive acute OCT finding in contusion maculopathy that correlates with photoreceptor disruption and variable visual outcomes.
CLINICAL AND DEMOGRAPHIC RISK FACTORS ASSOCIATED WITH RECURRENT AND FELLOW EYE RHEGMATOGENOUS RETINAL DETACHMENTS.
Felfeli et al.
Retina·Jan 1, 2026
This retrospective study of 794 patients found that pneumatic retinopexy and greater detachment extent significantly increase recurrence risk, while older age and male sex predict fellow eye involvement in rhegmatogenous retinal detachment.
PREVALENCE, RISK FACTORS, AND OUTCOMES OF RHEGMATOGENOUS RETINAL DETACHMENTS REPAIR IN MARFAN SYNDROME.
Nagshbandi et al.
Retina·Jan 1, 2026
In patients with Marfan syndrome, 33.1% developed rhegmatogenous retinal detachment over long-term follow-up, with successful reattachment achieved in 69.2% after primary repair and higher rates after secondary procedures.
PROLIFERATIVE VITREORETINOPATHY AND OUTER RETINAL FOLDS IN RHEGMATOGENOUS RETINAL DETACHMENT: Insights Into Retinal Remodeling.
Affatato et al.
Retina·Jan 1, 2026
PVR grade C significantly increases both the incidence and height of outer retinal folds (ORFs) one month after pars plana vitrectomy for rhegmatogenous retinal detachment, suggesting ORFs may serve as markers of retinal remodeling severity.
Diagnostic Accuracy of EyeArt for Fundus-Based Detection of Diabetic Retinopathy: A Systematic Review and Meta-analysis.
Wang et al.
Am J Ophthalmol·Jan 1, 2026
This systematic review and meta-analysis of 17 studies (162,695 examinations) found EyeArt AI system achieved 95% sensitivity and 81% specificity for detecting referable diabetic retinopathy from fundus photographs, supporting its use for autonomous screening in primary care settings.
Longitudinal Neural and Microvascular Changes in Type 2 Diabetic Patients Without Retinopathy: A 2-Year Prospective Cohort Study.
Fan et al.
Am J Ophthalmol·Jan 1, 2026
In type 2 diabetic patients without retinopathy, ganglion cell-inner plexiform layer thickness decreased 5-fold faster than controls over 2 years, while capillary vessel density remained unchanged, suggesting neurodegeneration precedes microvascular changes.
EXPANDED FIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY BIOMARKERS ASSOCIATED WITH THE DEVELOPMENT OF TRACTIONAL RETINAL DETACHMENT IN PROLIFERATIVE DIABETIC RETINOPATHY.
Lu et al.
Retina·Jan 1, 2026
Swept-source OCTA identified three key biomarkers associated with tractional retinal detachment development in PDR: large retinal nonperfusion areas, extensive neovascularization (>4 disc diameters), and tabletop neovascularization with anterior displacement.
RETINAL PHOTORECEPTORS AND ARTERIOLES ALTERATIONS DETECTED USING ADAPTIVE OPTICS SCANNING LASER OPHTHALMOSCOPY IN DIABETES AND DIABETIC RETINOPATHY.
Su et al.
Retina·Jan 1, 2026
Adaptive optics scanning laser ophthalmoscopy detected progressive photoreceptor loss and arteriolar wall thickening in diabetes patients, with changes correlating with diabetic retinopathy severity at the cellular level.
The Prevalence of Diabetic Retinopathy in American Indians or Alaska Natives and Non-Indigenous Americans: A Systematic Review and Meta-Analysis.
Yu et al.
Ophthalmology·Jan 1, 2026
A systematic review and meta-analysis of 53 studies found no significant difference in diabetic retinopathy prevalence between American Indian/Alaska Native (21%) and non-Indigenous American (20%) patients with diabetes.
Baseline OCT Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-analysis.
Nanji et al.
Ophthalmology·Jan 1, 2026
This systematic review and meta-analysis of 27 studies identified five OCT biomarkers consistently associated with worse visual acuity outcomes in diabetic macular edema patients at 6, 12, and 24 months after treatment initiation.
Timing of Preoperative Anti-VEGF for Vitrectomy in Proliferative Diabetic Retinopathy: A Competing-Risks Analysis of a Large Cohort.
Zhan et al.
Ophthalmol Retina·Dec 29, 2025
In this large cohort study of 608 PDR vitrectomy cases, preoperative anti-VEGF reduced postoperative vitreous hemorrhage but not traction retinal detachment risk, with optimal timing being 4-7 days before surgery.
International Consensus and Guidelines on Diagnosing and Managing Pachydrusen from APVRS, AEEC, APOIS, AAPPO, and ARI.
Sasaki et al.
Am J Ophthalmol·Jan 1, 2026
An international expert panel established consensus guidelines defining pachydrusen as distinct drusen subtypes ≥125 μm with irregular, multilobulated morphology and sharp borders, associated with increased choroidal thickness and ethnicity-related prevalence variations.
Real-World Experience With Intravitreal Pegcetacoplan for the Treatment of Geographic Atrophy in Age-Related Macular Degeneration.
Shen et al.
Am J Ophthalmol·Jan 1, 2026
Real-world use of intravitreal pegcetacoplan in 154 eyes with geographic atrophy demonstrated a 37% reduction in GA growth rate compared to pre-treatment rates, with similar efficacy for both foveal and nonfoveal lesions.
EFFECTS OF SOCIOECONOMIC FACTORS ON VISUAL OUTCOME AND MANAGEMENT OF PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION.
Barthelemy et al.
Retina·Jan 1, 2026
Lower socioeconomic status was associated with worse visual outcomes in wet AMD patients, with income level affecting both baseline and final visual acuity as well as choice of anti-VEGF agent.
CHANGES IN WIDEFIELD CHOROIDAL THICKNESS AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Wakugawa et al.
Retina·Jan 1, 2026
Anti-VEGF therapy for neovascular AMD causes extensive choroidal thinning across a wide retinal area, with greater thinning associated with better fluid resolution in pachychoroid neovasculopathy patients.
Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: Ninety-Six-Week Results from the Randomized Phase 3 PULSAR Trial.
Korobelnik et al.
Ophthalmology·Jan 1, 2026
Aflibercept 8 mg demonstrated non-inferiority to aflibercept 2 mg in treatment-naive nAMD patients through 96 weeks, allowing extended dosing intervals of 12-24 weeks while maintaining similar visual and anatomic outcomes with comparable safety.
AGE-RELATED RETINAL PIGMENT EPITHELIUM DISEASE: Clinical and Differential Features.
Arrigo et al.
Retina·Jan 1, 2026
This study describes age-related retinal pigment epithelium disease (ARPED), a newly characterized retinal condition affecting older patients that shows primary RPE involvement without typical AMD features like drusen or pachychoroid characteristics.
MORPHOMETRIC CHANGES IN MACULAR NEOVASCULARIZATION ARCHITECTURE AFTER FARICIMAB TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Comparison Between Naive and Switched Eyes.
Carlà et al.
Retina·Jan 1, 2026
Faricimab induces significant morphometric changes in macular neovascularization networks, with greater effects in treatment-naive eyes compared to switched eyes, primarily occurring during the loading phase.
RISK OF AGE-RELATED MACULAR DEGENERATION IN LATE-ONSET ATOPIC DERMATITIS: A Multidatabase Cohort Analysis.
Chen et al.
Retina·Jan 1, 2026
This large retrospective cohort study found that adults with atopic dermatitis have a significantly increased risk of developing age-related macular degeneration, with hazard ratios of 1.97 in the US cohort and 1.25 in the Taiwan cohort.
CRVO, BRVO, retinal ischemia, macular edema from RVO
Risk of Alzheimer Disease and Related Dementia after Retinal Vascular Occlusion: A Nationwide Cohort Analysis.
Tsai et al.
Ophthalmol Retina·Jan 1, 2026
This nationwide cohort study of 39,540 patients found that retinal vascular occlusion is associated with a 57% increased risk of Alzheimer's disease and 76% increased risk of vascular dementia.
Exogenous Testosterone Use Increases the Risk of Central Serous Chorioretinopathy.
Roig et al.
Am J Ophthalmol·Jan 1, 2026
This large-scale retrospective cohort study found that exogenous testosterone use significantly increases the risk of central serous chorioretinopathy by over 8-fold (adjusted OR: 8.05).
ARTIFICIAL INTELLIGENCE FOR THE DETECTION OF MACULOPATHY IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE.
Hoyek et al.
Retina·Jan 1, 2026
AI algorithms showed promise for detecting sickle cell maculopathy in pediatric patients using OCT imaging, with random forest achieving 96% accuracy in identifying retinal thinning.
Longitudinal Evaluation of Microvascular Changes and Imaging Biomarkers Associated with Visual Prognosis in Retinal Artery Occlusion.
Chen et al.
Am J Ophthalmol·Jan 1, 2026
This longitudinal study of 57 RAO eyes identified baseline macular ischemic area and foveal avascular zone (FAZ) area as independent predictors of final visual acuity, with potential for microvascular reperfusion in eyes with limited initial involvement.
Macular Edema Resistance in Retinal Vein Occlusion and the Protective Role of PAMM Subtypes.
Cicinelli et al.
Am J Ophthalmol·Jan 1, 2026
In RVO patients without macular edema at presentation, PAMM (particularly globular subtype) serves as a protective factor, with 42% developing macular edema within one year despite this initial resistance.
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGES 3 AND 4 PROLIFERATIVE SICKLE CELL RETINOPATHY RESULTS IN IMPROVED ANATOMICAL AND VISUAL OUTCOMES.
Lim et al.
Retina·Jan 1, 2026
Anti-VEGF therapy for stages 3 and 4 proliferative sickle cell retinopathy achieved disease control in 93% of eyes within one month, with visual improvement particularly notable in stage 4 cases and minimal need for vitrectomy.
Vision Outcomes in Children Treated With Voretigene Neparvovec for RPE65-Associated Retinopathy.
Thompson et al.
JAMA Ophthalmol·Jan 2, 2026
Voretigene neparvovec gene therapy in 14 pediatric patients with RPE65-associated retinopathy demonstrated visual improvements measurable by pattern VEPs, though visual acuity improvements were modest when excluding off-chart conversions.
Phenotypic Manifestations in Female Carriers of RPGR ORF15 Variants Causing X-Linked Cone Dystrophy.
Raji et al.
JAMA Ophthalmol·Jan 2, 2026
Female carriers of RPGR ORF15 variants causing X-linked cone dystrophy exhibit a distinct phenotype with mild cone dysfunction, macular changes limited to the posterior pole, and preserved peripheral retina, differing from carriers of rod-cone dystrophy variants.
Collision of Retinitis Pigmentosa and Von-Hippel Lindau Disease.
Zhuang et al.
Am J Ophthalmol·Jan 1, 2026
Insufficient information provided - only title and authors are available for this case report on the co-occurrence of retinitis pigmentosa and Von Hippel-Lindau disease.
Smartphone-Driven Augmented Reality Headset for Low-Light Mobility Assistance in Retinitis Pigmentosa.
Rubegni et al.
Am J Ophthalmol·Jan 1, 2026
A smartphone-driven AR headset significantly improved mobility performance and visual field function in retinitis pigmentosa patients, with 88% able to complete mobility testing at 1 lux compared to 0% without the device.
Development and Validation of a Commercially Available Two Color Dark Adapted Perimetry to Assess Inherited Retinal Degenerations.
Pennesi et al.
Am J Ophthalmol·Jan 1, 2026
Researchers developed and validated a commercially available 2-color dark-adapted perimetry protocol using the Octopus 900 Pro that can differentiate rod and cone function in retinitis pigmentosa patients, demonstrating superior sensitivity to early rod function loss compared to standard perimetry.
Ocular Manifestations of ROSAH Syndrome Caused by Different Mutations of the ALPK1 Gene.
Sun et al.
Am J Ophthalmol·Jan 1, 2026
This case series of 5 patients with ROSAH syndrome identifies distinct ocular manifestations including persistent optic disc edema and progressive retinal degeneration resembling retinitis pigmentosa, with a novel ALPK1 mutation (T237A) causing a milder phenotype with isolated ocular symptoms.
NOVEL METHOD OF DETECTION OF BIREFRINGENT OCULAR AMYLOIDOSIS DEPOSITS USING MONOCHROMATIC WAVELENGTHS OF SCANNING LASER OPHTHALMOSCOPY.
Zafar et al.
Retina·Jan 1, 2026
A novel noninvasive imaging technique using ultra-widefield scanning laser ophthalmoscopy with monochromatic wavelengths can detect ocular amyloidosis deposits with high specificity (100%) by identifying characteristic patterns on red and green filtered images.
USING ARTIFICIAL INTELLIGENCE TO ASSESS MACULAR EDEMA TREATMENTS IN RETINITIS PIGMENTOSA.
Most et al.
Retina·Jan 1, 2026
A deep learning AI tool accurately quantified intraretinal fluid in retinitis pigmentosa-associated macular edema, demonstrating that oral acetazolamide significantly reduces fluid volume and improves visual acuity over time, while topical carbonic anhydrase inhibitors show no significant benefit.
Circinate Midperipheral Vitelliform Dystrophy With Macular Sparing in the Father of a Patient With Best Disease.
Formenti et al.
Retina·Jan 1, 2026
This case report describes a novel presentation of circinate midperipheral vitelliform dystrophy with macular sparing in the father of a patient with Best disease, suggesting potential genetic heterogeneity in vitelliform dystrophies.
Management of Retinopathy of Prematurity in the Anti-VEGF Era: Consensus and Recommendations From the Taiwan Pediatric Retina (TPR) Group.
Lai et al.
Am J Ophthalmol·Jan 1, 2026
A Taiwanese expert panel developed evidence-based consensus recommendations for ROP management, endorsing both anti-VEGF therapy and laser photocoagulation as acceptable first-line treatments for type 1 ROP with individualized treatment selection.
Clinical Characteristics and Long-term Visual Prognosis of Familial Exudative Vitreoretinopathy.
Chokchaitanasin et al.
Am J Ophthalmol·Jan 1, 2026
This retrospective study of 92 eyes with FEVR found that most patients (62%) required no treatment, but advanced stages (≥4) were significantly associated with poor visual outcomes despite surgical intervention.
Cellular-Level Assessment of Macular Development in Patients With Familial Exudative Vitreoretinopathy Using Multimodal Imaging: A Prospective Cohort Study.
Hu et al.
Am J Ophthalmol·Jan 1, 2026
FEVR patients without foveal hypoplasia demonstrate irregular foveal avascular zone morphology and abnormal cone photoreceptor distribution, with lower foveal but higher parafoveal cone densities compared to healthy controls.
Evaluation of an Association between COVID-19 and Retinal Hemorrhage in Children.
Zhao et al.
Ophthalmology·Jan 1, 2026
This retrospective cohort study of 6,952 children found no association between COVID-19 infection and retinal hemorrhage across multiple time intervals. All children with both positive COVID-19 tests and retinal hemorrhages had alternative explanatory causes.
Giant Macular Hole in Regressed Retinopathy of Prematurity.
Ratra et al.
Retina·Jan 1, 2026
This case report describes a rare occurrence of a giant macular hole developing in an eye with regressed retinopathy of prematurity, highlighting an unusual late complication in ROP patients.
Cost Analysis of Risk Stratified Retinopathy of Prematurity Screening.
Hwang et al.
Ophthalmol Retina·Dec 30, 2025
Risk-stratified ROP screening using TWO-ROP and FIRST-ROP algorithms can significantly reduce neonatal healthcare costs in the United States while maintaining safety by decreasing the number of required inpatient examinations.
APMPPE Presenting with BALAD: Imaging Features for Differential Diagnosis of Choroiditis and Non-Invasive Follow-Up.
Belletti et al.
Ocul Immunol Inflamm·Jan 2, 2026
A case report describes APMPPE presenting with unilateral bacillary layer detachment (BALAD), emphasizing the importance of multimodal imaging for differential diagnosis of choroiditis and non-invasive monitoring of treatment response.
HELLP Syndrome associated chorioretinopathy with uveal effusion.
Lin et al.
Am J Ophthalmol·Jan 1, 2026
Insufficient information provided - only title and authors were given without abstract content to summarize the clinical findings regarding HELLP syndrome-associated chorioretinopathy with uveal effusion.
Clinical and Organizational Determinants of a Frequently Delayed Diagnosis of Ocular Syphilis in a French Referral Center.
Brocquet-Lestrade et al.
Am J Ophthalmol·Jan 1, 2026
A French study of 72 patients with ocular syphilis found that diagnostic delays >4 weeks occurred only in patients who first consulted private practice ophthalmologists, and longer delays were associated with poorer visual outcomes.
AI-Driven Optical Coherence Tomography Biomarkers for Choroidal Neovascularization Assessment in Punctate Inner Choroidopathy and Multifocal Choroiditis.
Ferro Desideri et al.
Am J Ophthalmol·Jan 1, 2026
AI-driven OCT analysis identified larger baseline lesion volume and longer disease duration as key predictors of secondary CNV development in patients with punctate inner choroidopathy and multifocal choroiditis.
Ocular Comorbidities of Psoriasis: A Systematic Review and Meta-analysis of Observational Studies.
Wang et al.
Am J Ophthalmol·Jan 1, 2026
This systematic review and meta-analysis of 34 studies involving over 10 million subjects demonstrates that psoriasis patients have significantly increased risk for multiple ocular comorbidities, including retinal vein occlusion (HR 1.58) and glaucoma (HR 1.40).
CARBONIC ANHYDRASE INHIBITORS FOR MANAGING UVEITIC MACULAR EDEMA: A Systematic Review and Meta-Analysis.
Excelinda et al.
Retina·Jan 1, 2026
This systematic review and meta-analysis of 7 studies (187 participants, 236 eyes) found that oral acetazolamide achieved visual acuity improvement in 53% and anatomical improvement in 55% of patients with uveitic macular edema.
Clinical Assessment of a Highly Multiplexed Panel Assay for the Diagnosis of Infectious Uveitis.
Bispo et al.
Am J Ophthalmol·Dec 31, 2025
The OcuPan assay, a highly multiplexed panel detecting 46 ocular pathogens, demonstrated 50.9% sensitivity and 100% specificity for diagnosing infectious uveitis, with excellent agreement (93.5%) compared to PCR testing.
Management and outcomes of cataract surgery in uveitic eyes with chronic hypotony: a two-case series.
Alhaimi et al.
J Ophthalmic Inflamm Infect·Dec 29, 2025
A multi-modal approach involving aggressive immunosuppression, periocular steroid injections to elevate IOP, and intentional aphakia after lens aspiration achieved successful visual outcomes in two young patients with uveitic cataracts and chronic hypotony.
Assessment of Sensorimotor Complications After Plaque Brachytherapy for Patients With Uveal Melanoma.
Munkwitz et al.
Am J Ophthalmol·Jan 1, 2026
Diplopia occurs in 38.9% of patients after I-125 plaque brachytherapy for uveal melanoma but typically resolves spontaneously within 6 months, while strabismus develops in 7.2% of cases.
Enucleation of an Eye With Potential High-Risk Retinoblastoma Is Currently Important for Patient Survival.
Shields et al.
Retina·Jan 1, 2026
Based on the title alone, this study emphasizes that enucleation remains a critical intervention for eyes with high-risk retinoblastoma features to ensure patient survival.
Elevated Lactic Acid Levels in the Aqueous Humor May Be an Indicator of Uveal Melanoma.
Miller et al.
Am J Ophthalmol·Jan 1, 2026
Aqueous humor L-lactate levels were significantly elevated in uveal melanoma eyes compared to controls and correlated with tumor mitotic activity, suggesting potential utility as a diagnostic biomarker.
Adjuvant Chemotherapy in Retinoblastoma with Post-laminar Optic Nerve Invasion: A Global Multicenter Study.
Lin et al.
Ophthalmol Retina·Dec 29, 2025
This multicenter study of 292 retinoblastoma patients with post-laminar optic nerve invasion demonstrates that adjuvant chemotherapy after primary enucleation significantly reduces orbital recurrence, metastasis, and death compared to no adjuvant therapy.
Endophthalmitis, surgical complications, drug safety, adverse events
Prevalence of Intravitreal Silicone Oil Following Intravitreal Injections: A Meta-Analysis.
Chavez et al.
Am J Ophthalmol·Jan 1, 2026
This meta-analysis of 1,583 eyes found that intravitreal silicone oil contamination occurs in 57.56% of eyes following intravitreal injections, with floaters developing in 27.85% of cases.
KIDNEY INJURY DURING TREATMENT WITH AFLIBERCEPT VERSUS RANIBIZUMAB: A Population-Based Study.
Campbell et al.
Retina·Jan 1, 2026
A large population-based study of 44,571 patients found no significant difference in kidney injury risk between intravitreal aflibercept and ranibizumab despite aflibercept's greater systemic VEGF suppression.